PTC Therapeutics | PTCT - Capitale Di Prestito





Capitale Di Prestito Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
Amgen USD 51.89B 1.88B 2026-03
BioCryst Pharmaceuticals USD 395.2M 33.48M 2026-03
Biogen USD 7.29B 1B 2026-06
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Cytokinetics USD 247.21M 868.77M 2026-03
Daiichi Sankyo JPY 500B 199.92B 2026-06
Enanta Pharmaceuticals USD 0 0 2024-12
Gilead Sciences USD 20.86B 1.27B 2026-03
Incyte USD 28.42M 994K 2026-06
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
Novartis USD 37.49B 42M 2026-06
Pfizer USD 60.57B 1.08B 2026-03
PTC Therapeutics USD 535.52M 248.58M 2026-06
Puma Biotechnology USD 10.87M 222K 2025-06
Roche Holding CHF 25.22B 2.21B 2026-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 838.16M 9.19M 2026-03
TG Therapeutics USD 745.14M 499.5M 2026-03
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12
Xencor USD 82.12M 5.64M 2026-03